Key Highlights

  • Pixelworks (NASDAQ:PXLW) climbed 20.61% at a relative Volume of 689.62. ATA Creativity Global (NASDAQ:AACG) climbed 21.33% at a relative volume of 593.06. Published coverage identified no catalyst for either.
  • Autonomix Medical (NASDAQ:AMIX) surged 51.76% on 48.46 million shares, about 24.7 times its share count (calculated). MIND C.T.I. (NASDAQ:MNDO) surged 43.80% on 10.07 million shares, with a Market Value of USD 25.49 million.
  • Lichen International (NASDAQ:LICN) tumbled 84.46% to USD 0.0474 on 25.19 million shares, a relative volume of 211.14, and published coverage identified no catalyst.
  • Implied average volumes were tiny, from about 10,926 shares for ATA Creativity to 119,300 shares for Lichen International (calculated), which amplifies the effect of each trade.

Pixelworks (NASDAQ:PXLW): Up 20.61% With No Catalyst Identified Ahead of Results

Pixelworks (NASDAQ:PXLW) finished at USD 6.29, a gain of 20.61% from a calculated prior close of USD 5.22, on 14.85 million shares at a relative volume of 689.62, roughly 690 times an implied average near 21,534 shares (calculated). Turnover of about USD 93.41 million (calculated) is larger than the USD 38.05 million market value. Published coverage showed no release, filing or analyst action dated November 9 or 10. The company is due to report third-quarter results on November 11, 2026, which is general context and not a confirmed cause. The second-quarter release showed cash of USD 52.9 million, about 139% of market value (calculated), a net loss of USD 2.8 million and EPS of USD -0.44. Its Revenue figure of USD 64 thousand is unusually small and should be checked. A small float means a few trades can move the price. A 20.61% gain ahead of Earnings can reverse, and nothing suggests the gain will continue.

ATA Creativity Global (NASDAQ:AACG): Up 21.33% With No Catalyst Identified

ATA Creativity Global (NASDAQ:AACG), the Chinese creative arts education company, finished at USD 0.7098, a gain of 21.33% from a calculated prior close of USD 0.5850. Trading of 6.48 million at a relative volume of 593.06 implies an average of only about 10,926 shares (calculated), so dollar turnover of roughly USD 4.60 million is large next to a USD 25.17 million market value. Published coverage showed no release, filing or analyst action dated November 9 or 10. Earlier items include a proposed sale of ATA BVI and a 69.0417% stake in Huanqiuyimeng for RMB 1 alongside a private Placement of 45,306,792 shares, and the outcome was not confirmed. The USD 25.17 million value implies about 35.46 million shares (calculated), so the snapshot may be stale. The close is under USD 1.00, so the Nasdaq minimum bid rule remains a risk, along with dilution. A few trades can move the price, and the gain can reverse fast. The stock finished at USD 0.7098, 29.0% under the USD 1.00 bid level (calculated).

Autonomix Medical (NASDAQ:AMIX): Up 51.76% With No Catalyst Identified

Autonomix Medical (NASDAQ:AMIX) finished at USD 2.58, a gain of 51.76% from a calculated prior close of USD 1.70, after rising 11.84% on November 9. Trading of 48.46 million shares was about 141 times the 342,889 traded on November 9 and about 24.7 times the share count (calculated). No company release dated November 9 or 10 turned up, and the newest items were a September 30, 2026 FDA pre-submission feedback report on a 510(k) pathway and an early October patent. As general context, pre-revenue device names often leap on regulatory headlines, financing or short covering, none confirmed. The market value is USD 5.06 million, about 0.51 times the USD 9.9 million cash reported at December 31, 2025 (calculated). The 52-week range is USD 1.46 to USD 32.55, and the company needs USD 30 million to USD 36 million more, so dilution is the central risk. Gains of this size often reverse.

MIND C.T.I. (NASDAQ:MNDO): Up 43.80% With No Catalyst Identified

MIND C.T.I. (NASDAQ:MNDO), an Israeli billing and messaging software company, finished at USD 1.2511, a gain of 43.80% from a calculated prior close of USD 0.8700, on 10.07 million shares against an average near 37,544 (calculated), about 268 times normal. Three lookups found no results release, dividend, Merger or filing dated November 9 or 10. The August 6, 2026 report showed second-quarter revenue of USD 4.6 million, Operating Income of USD 0.7 million and EPS of USD 0.04, with cash and securities of USD 13.5 million at June 30. The market value is USD 25.49 million, about 20.37 million shares (calculated), the P/E is 7.85 on trailing diluted EPS of USD 0.16, and the close is 40.9% over the USD 0.8879 quote of October 30 (calculated). A Nasdaq bid price notice dated June 23 allows until December 21, 2026 to regain compliance, and the close is 25.1% over USD 1.00 (calculated). Leadership is interim with Monica Iancu as CEO, spreads can be wide, and the move may reverse. Nothing suggests it will continue. The company bought back 617,000 shares under its repurchase program.

Lichen International (NASDAQ:LICN): Down 84.46% With No Catalyst Identified

Lichen International (NASDAQ:LICN), a Hong Kong based commercial services firm, finished at USD 0.0474, a fall of 84.46% from a calculated prior close of USD 0.3050, or USD 0.2576 per share. Trading of 25.19 million shares at a relative volume of 211.14 was worth about USD 1.19 million (calculated). Two searches found no results, contract, Bankruptcy or reverse split dated November 9 or 10. As general context, slides of this size in sub-dollar names often tie to discounted offerings, note conversions or delisting notices, none confirmed. The market value is USD 4.98 million, about 105.1 million shares (calculated), while a statistics page showed 16.44 million shares and USD 1.24 on August 25, 2026, a conflict left unresolved. Snapshot EPS is USD -1.48, and older cash of USD 26.91 million would exceed market value, which looks unverified. It is a nano-cap in which a few trades can move the price.

Where Things Stand

The largest unusual-volume mover on November 10, 2026 was Lichen International (NASDAQ:LICN), down 84.46%. Autonomix Medical (NASDAQ:AMIX) led the gainers at 51.76%. The shared feature is trading far above a very small normal base, with relative volumes of 211.14 to 689.62 in four cases. Large one-day moves in thinly traded names can reverse the next session because a few orders set the price and spreads can be wide. These lists rest on a published screener snapshot of the regular session on November 10, 2026.